Literature DB >> 16765133

Fatal pulmonary embolism and stroke.

Elias Skaf1, Paul D Stein, Afzal Beemath, Julia Sanchez, Ronald E Olson.   

Abstract

Death from pulmonary embolism (PE) in patients with ischemic stroke was determined from the United States Census Bureau's Compressed Mortality File, which is based on all death certificates throughout the United States. Among patients with ischemic stroke who died over a 19-year study period, PE was the listed cause of death in 11,101 of 2,000,963 individuals (0.55%). On the basis of an assumed sensitivity of death certificates for fatal PE of 26.7% to 37.2%, the corrected rate of fatal PE was 1.5% to 2.1%. Death rates from PE in patients with ischemic stroke decreased from 1980 to 1998. A decrease over 2 decades in the rate of deaths from PE in patients with ischemic stroke is compatible with the increasing and effective use of antithrombotic prophylaxis.

Entities:  

Mesh:

Year:  2006        PMID: 16765133     DOI: 10.1016/j.amjcard.2006.01.042

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Prescription of enoxaparin is associated with decreasing pulmonary embolism mortality rate in Germany.

Authors:  Carolin Pütter; Olga von Beckerath; Hanna Maria Sobik; Holger Reinecke; Jürgen Stausberg; Knut Kröger
Journal:  J Thromb Thrombolysis       Date:  2015-11       Impact factor: 2.300

2.  The epidemiology of pulmonary embolism: racial contrasts in incidence and in-hospital case fatality.

Authors:  Dona Schneider; David E Lilienfeld; Wansoo Im
Journal:  J Natl Med Assoc       Date:  2006-12       Impact factor: 1.798

3.  Incidence rate of pulmonary embolism in Germany: data from the federal statistical office.

Authors:  K Kröger; Ch Moerchel; Th Moysidis; F Santosa
Journal:  J Thromb Thrombolysis       Date:  2010-04       Impact factor: 2.300

4.  Pulmonary embolism in ischemic stroke: clinical presentation, risk factors, and outcome.

Authors:  Jitphapa Pongmoragot; Alejandro A Rabinstein; Yongchai Nilanont; Richard H Swartz; Limei Zhou; Gustavo Saposnik
Journal:  J Am Heart Assoc       Date:  2013-11-25       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.